Maike Windbergs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maike Windbergs has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Lutz Franzen
Saarland University, Department of Biopharmaceutics and Pharmaceutical Technology, Saarbruecken, Germany
5 shared publications- Claus-Michael Lehr
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, 66123 Saarbrücken, Germany
4 shared publications Birthe Kann
Saarland University, Department of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, Campus A4.1, 66123 Saarbruecken, Germany; University of Twente, Optical Sciences Group, MESA+ Institute for Nanotechnology, P.O. Box 217, 7500 AE Enschede, The Netherlands
3 shared publicationsSalem Seif
3 shared publicationsViktoria Planz
3 shared publicationsB. Sterner
Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany; Pharmbiotec GmbH, Saarland University, Campus C 2.2, 66123 Saarbrücken, Germany
2 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Toxicology Letters
- Vol. 280, S224
Simulating human skin wounds – Perspectives on non-animal alternatives for bio-relevant testing of pharmaceuticals
- 1 October 2017
- Published by Elsevier in Toxicology Letters
- Vol. 280, S224
Simulating human skin wounds – Perspectives on non-animal alternatives for bio-relevant testing of pharmaceuticals
- 17 February 2016
- Published by Wiley in Journal of Raman Spectroscopy
- Vol. 47 (7) , 757-762
Novel insights into controlled drug release from coated pellets by confocal Raman microscopy
The development of novel therapeutics with improved efficacy implies increasing complexity of drug delivery systems, which in turn require advanced methods for their analytical characterization. Among these systems, pellets represent upcoming carrier systems, which show several advantages like simplified dosing and improved compliance among children and the aged population. However, rational development of such systems is hampered by the lack of non‐destructive, chemically selective analytical insight into compound distribution and drug release mechanisms. The aim of this study was to evaluate confocal Raman microscopy (CRM) for investigation of coated drug‐loaded pellets based on visualization of compound distribution and elucidation of drug release mechanisms. Three complementary approaches were applied for pellet characterization: analysis of cross sections after bisectioning, non‐invasive visualization of the pellet surface, and virtual cross sectioning in x–z direction. As the surface of such pellets is structured, a complementary approach of optical topography and CRM was applied for three‐dimensional analysis. Based on the individual Raman peak patterns, the drug and excipients forming the matrix of the pellets and the film coating were successfully visualized with high spatial resolution, verifying homogeneous drug distribution and intact polymer coating of the pellet. Further, analysis of the pellets after certain time intervals during drug release testing revealed pore formation in the polymer coating facilitating drug release and preceding drug depletion in the pellets matrix. CRM represents an upcoming technique for analytical characterization of carrier systems and elucidation of their complex drug release mechanisms, thus supporting rational development of novel therapeutics. Copyright © 2016 John Wiley & Sons, Ltd.
- 17 February 2016
- Published by Wiley in Journal of Raman Spectroscopy
- Vol. 47 (7) , 757-762
Novel insights into controlled drug release from coated pellets by confocal Raman microscopy
The development of novel therapeutics with improved efficacy implies increasing complexity of drug delivery systems, which in turn require advanced methods for their analytical characterization. Among these systems, pellets represent upcoming carrier systems, which show several advantages like simplified dosing and improved compliance among children and the aged population. However, rational development of such systems is hampered by the lack of non‐destructive, chemically selective analytical insight into compound distribution and drug release mechanisms. The aim of this study was to evaluate confocal Raman microscopy (CRM) for investigation of coated drug‐loaded pellets based on visualization of compound distribution and elucidation of drug release mechanisms. Three complementary approaches were applied for pellet characterization: analysis of cross sections after bisectioning, non‐invasive visualization of the pellet surface, and virtual cross sectioning in x–z direction. As the surface of such pellets is structured, a complementary approach of optical topography and CRM was applied for three‐dimensional analysis. Based on the individual Raman peak patterns, the drug and excipients forming the matrix of the pellets and the film coating were successfully visualized with high spatial resolution, verifying homogeneous drug distribution and intact polymer coating of the pellet. Further, analysis of the pellets after certain time intervals during drug release testing revealed pore formation in the polymer coating facilitating drug release and preceding drug depletion in the pellets matrix. CRM represents an upcoming technique for analytical characterization of carrier systems and elucidation of their complex drug release mechanisms, thus supporting rational development of novel therapeutics. Copyright © 2016 John Wiley & Sons, Ltd.
- 1 January 2016
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 23 (2) , 6-11
Monitoring Drug Release from Electrospun Fibers Using an In Situ Fiber-Optic System
- 1 January 2016
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 23 (2) , 6-11
Monitoring Drug Release from Electrospun Fibers Using an In Situ Fiber-Optic System
- Open Access
- 1 January 2016
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 8 (7) , 775-784
Three-dimensional hierarchical cultivation of human skin cells on bio-adaptive hybrid fibers
Bio-adaptive hybrid fibers simulating the complex biomechanical characteristics of the native human extracellular matrix were developed as bio-inspired functional materials for biomedical applications.
- 1 January 2016
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 8 (7) , 775-784
Open AccessThree-dimensional hierarchical cultivation of human skin cells on bio-adaptive hybrid fibers
Bio-adaptive hybrid fibers simulating the complex biomechanical characteristics of the native human extracellular matrix were developed as bio-inspired functional materials for biomedical applications.
- 1 January 2016
- Published by Walter de Gruyter GmbH
Nanomedicines for the treatment of inflammatory bowel diseases
Inflammatory bowel disease (IBD) mainly comprises Crohn’s disease and ulcerative colitis and is considered an idiopathic disease affecting the entire gastrointestinal tract. Various approaches have been proposed for the treatment of IBD, but the development of an appropriate delivery system to specifically target different sites of inflammation in the gut has remained a challenge. The therapeutic approaches available to date are not considered to be completely effective due to severe systemic side effects. Instead, a carrier system that could deliver the drug exclusively to the target site would be desirable. Nanomedicine offers new hope for diagnosis and targeted delivery of drugs. In the context of IBD, nanomedicines can accumulate in inflamed tissue forming a drug depot at the site of action and reducing both dosing frequency and possible adverse effects. In this review, we discuss the advancement in drug delivery provided by nanomedicines compared to classical drug delivery approaches, as well as the application of nanocarriers for biologicals and other next generation anti-inflammatory drugs.
- 1 January 2016
- Published by Walter de Gruyter GmbH
Nanomedicines for the treatment of inflammatory bowel diseases
Inflammatory bowel disease (IBD) mainly comprises Crohn’s disease and ulcerative colitis and is considered an idiopathic disease affecting the entire gastrointestinal tract. Various approaches have been proposed for the treatment of IBD, but the development of an appropriate delivery system to specifically target different sites of inflammation in the gut has remained a challenge. The therapeutic approaches available to date are not considered to be completely effective due to severe systemic side effects. Instead, a carrier system that could deliver the drug exclusively to the target site would be desirable. Nanomedicine offers new hope for diagnosis and targeted delivery of drugs. In the context of IBD, nanomedicines can accumulate in inflamed tissue forming a drug depot at the site of action and reducing both dosing frequency and possible adverse effects. In this review, we discuss the advancement in drug delivery provided by nanomedicines compared to classical drug delivery approaches, as well as the application of nanocarriers for biologicals and other next generation anti-inflammatory drugs.
- 1 October 2015
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 78, 204-213
Skin penetration behavior of lipid-core nanocapsules for simultaneous delivery of resveratrol and curcumin
- 1 October 2015
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 78, 204-213
Skin penetration behavior of lipid-core nanocapsules for simultaneous delivery of resveratrol and curcumin
- 1 September 2015
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 95, 110-116
Quantitative detection of caffeine in human skin by confocal Raman spectroscopy – A systematic in vitro validation study
- 1 September 2015
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 95, 110-116
Quantitative detection of caffeine in human skin by confocal Raman spectroscopy – A systematic in vitro validation study